A Study on Etiological Factors of Schizophrenia
NCT00155636 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 1056
Last updated 2005-11-28
Summary
This PPG entitled "A Study on Etiological Factors of Schizophrenia" (SEFOS) focuses on searching for the separate etiological factors under the understanding that schizophrenia is a complex disorder. Multifactorial model has been most often proposed as the etiological model. Up to now, fragmented knowledge of etiological factors, including genetic factor and environmental insults were reported in literature, and a two-strike hypothesis has been proposed. This PPG of SEFOS formulates a dynamic etiological hypothesis of schizophrenia. Specific, however heterogeneous, genes are hypothesized to be located in chromosome 1q, 6P, 8P, 15q, and 22q; specific environmental insults or stress are hypothesized to be acting in the vulnerable brain a long different stages of biological and/or psychological development. The interaction of specific genes and specific environment insults/stress along different stages of development will result in specific neurobiological abnormalities as shown in neuropsychological, neurophysiological and neurochemical/neuroimaging abnormalities. For this hypothesis testing, this PPG of SEFOS designs 3 projects of: (1) A Study on Neurobiology of Schizophrenia; (2) A Study on Environmental insults/stress of schizophrenia; and (3) Molecular Genetics Study of Schizophrenia. Project No.1 aims at finding different levels of neurobiological and anatomical abnormalities; Project No.2 aims at finding different levels of environmental insults/ stress; Project No.3 aims at locating vulnerability genes in different chromosome regions. A core unit for administrative integration, for case/family recruitment and statistical analysis is also designed. The dynamic etiological complex will be explored under multivariate statistical analysis. This PPG of SEFOS adopts multidisciplinary approach including clinical psychiatrists, psychopathologists, neuropsychologist, neurophysiologist, neuroimaging (magnetic resonance imaging) specialist, genetic epidemiologist, molecular genetic specialist, genetic statistician, and biostatisticians. This team has sound mutual trust base on the experience of being working together and attending regular research meeting for the part several years under the leadership of the principal investigator of this PPG.
Conditions
Sponsors & Collaborators
-
National Taiwan University Hospital
lead OTHER
Principal Investigators
-
Hai-Gwo Hwu, Professor · National Taiwan University
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2002-01-31
- Completion
- 2005-12-31
More Related Trials
-
Exploring the Effectiveness of Group Cognitive Stimulation Therapy in People With Schizophrenia.
NCT04916483 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of the Functional Remission Occurrence and Predictive Factors in Schizophrenia
NCT02874560 ·Status: COMPLETED
-
Predictors of Functional Remission in Discharged Patients With Schizophrenia After Long-term Drug Discontinuation
NCT05667961 ·Status: COMPLETED
-
Dual Modulation of Sigma-1 and NMDA Receptors in the Treatment of Schizophrenia
NCT06574360 ·Status: RECRUITING ·Phase: PHASE2
-
Effect of Memantine on ERP in Early Schizophrenia and Healthy Subjects
NCT02233556 ·Status: UNKNOWN ·Phase: NA
-
Effects of Gene Polymorphisms on Metabolic Features in Clozapine-treated Patients With Schizophrenia
NCT01324167 ·Status: UNKNOWN
-
The Establishment of the Early Intervention Program for Patients With Schizophrenia
NCT00172770 ·Status: UNKNOWN
-
Genetic Study of Schizophrenia
NCT00001486 ·Status: COMPLETED
-
Efficacy of Chronic Disease Self-management Program in People With Schizophrenia
NCT04503954 ·Status: COMPLETED ·Phase: NA
-
Adherence and Quality of Life in People With Schizophrenia and Schizoaffective Disorder
NCT01769014 ·Status: UNKNOWN
-
A Study on Evaluation of Mental Health Index of Patients With Psychiatric Disorders
NCT00166764 ·Status: UNKNOWN
-
Effect of Add-on Citalopram to Risperidone on Negative Symptoms in Schizophrenia
NCT00893256 ·Status: COMPLETED ·Phase: PHASE4
-
Factors Influencing Social Functioning of People With Schizophrenia
NCT02166918 ·Status: COMPLETED
-
Biological Implications of the Overlapping Phenomenon Between Childhood Schizophrenia and Autism Spectrum Disorders-Heterogeneity Approach Rather Than Diagnostic Boundary
NCT06063525 ·Status: UNKNOWN
-
The Genetic Basis of Inherited Neurologic Deficits in People With Schizophrenia
NCT00247637 ·Status: COMPLETED
-
Safety and Efficacy of Study Drug Versus Placebo for Negative Symptoms of Schizophrenia
NCT00063297 ·Status: COMPLETED ·Phase: PHASE2
-
Multi-site Communication Deficits in Schizophrenia
NCT01317121 ·Status: COMPLETED
-
Observational Study to Evaluate Efficacy and Remission Status for Schizophrenia Patients Under Atypical Treatment
NCT00809731 ·Status: COMPLETED
-
A Non-Interventional Study of Patients With Persistent Symptoms of Schizophrenia to Describe Medical Resource Utilization and Burden of Illness
NCT01959659 ·Status: COMPLETED
-
Immunoinflammatory State Detection and Multimodal Brain Imaging and Electrophysiologic Changes in Schizophrenia
NCT06673966 ·Status: RECRUITING
-
A Survey of Sexual Function in Schizophrenic Patients
NCT01835522 ·Status: WITHDRAWN
-
Evaluation of Stroop Effect in Patients With Schizophrenia
NCT03163706 ·Status: UNKNOWN ·Phase: NA
-
Qualitative Analysis on the Experiences of Employment Among Schizophrenic Patients
NCT00423033 ·Status: COMPLETED
-
Measurement of Activity Participation for Persons With Schizophrenia Living in the Community
NCT00172731 ·Status: COMPLETED
-
Efficacy and Safety of Psychopharmacotherapy in Patients With Schizophrenia or Bipolar Disorders
NCT00330226 ·Status: UNKNOWN